[1] VERHOEF J.Antibiotic resistance:the pandemic[J].Advances in Experimental Medicine and Biology, 2003, 531:301-313.[2] OVERBYE K M, BARRETT J F.Antibiotics:where did we go wrong?[J].Drug Discovery Today, 2005, 10(1):45-52.[3] NIAID.NIAID Global health research plan for HIV/AIDS, malaria, and tuberculosis[R].USA:NIAID, 2001.
[4] SHINGADIA D, NOVELLI V.Diagnosis and treatment of tuberculosis in children[J].The Lancet Infectious Diseases, 2003, 3(10):624-632.
[5] GILLOR O, KIRKUP B C, RILEY M A.Colicins and microcins:the next generation antimicrobials[J].Advances in Applied Microbiology, 2004, 54:29-146.
[6] BOYLE-VAVRA S, DAUM R S.Community-acquired methicillin-resistant
Staphylococcus aureus:the role of Panton-
Valentine leukocidin[J].Laboratory Investigation, 2007, 87(1):3-9.
[7] NES I F, DIEP D B, HOLO H.Bacteriocin diversity in
Streptococcus and
Enterococcus[J].Journal of Bacteriology, 2007, 89(4):1189-1198.
[8] GUANÍ-GUERRA E, SANTOS-MENDOZA T, LUGO-REYES S O, et al.
Antimicrobial peptides:general overview and clinical implications in human health and disease[J].Clinical Immunology, 2010, 135(1):1-11.
[9] GRATIA A.Sur un remarquable exemple d'antagonisme entre deux souches de coilbacille[J].Comptes Rendus des Séances de la Sociétéde Biologie, 1925, 93:1040-1041.
[10] FREDERICQ P.Bacteriology of gastroenteritis in children caused by several strains of
Escherichia coli[J].Revue Medicale de Liege, 1957, 12(24):697-700.
[11] ROGERS L A.The inhabitting effect of streptococcus lactis on lactobacillus bulgaricus[J].Bacterio, 1928, 16(5):321-325.
[12] KIRKUP B C J.Bacteriocins as oral and gastrointestinal antibiotics:theoretical considerations, applied research, and practical applications[J].Current Medicinal Chemistry, 2006, 13(27):3335-3350.
[13] KLAENHAMMER T R.Bacteriocins of lactic acid bacteria[J].Biochimie, 1988, 70(3):337-349.
[14] JACK R W, TAGG J R, RAY B.Bacteriocins of gram-positive bacteria[J].Microbiology Reviews, 1995, 59(2):171-200.
[15] COTTER P D, HILL C, ROSS R P.Food microbiology:bacteriocins:developing innate immunity for food[J].Nature Reviews Microbiology, 2005, 3(10):777-788.
[16] DUQUESNE S, DESTOUMIEUX-GARZN D, PEDUZZI J, et al.Microcins, gene-encoded antibacterial peptides from enterobacteria[J].Nature Product Reports, 2007, 24(4):708-734.
[17] NOVOA M A, DIAZ-GUERRA L, SAN MILLN J L, et al.Cloning and mapping of the genetic determinants for microcin C7 production and immunity[J].Journal of Bacteriology, 1986, 168(3):1384-1391.
[18] SALOMÓN R A, FARÍAS R N.Microcin 25, a novel antimicrobial peptide produced by
Escherichia coli[J].Journal of Bacteriology, 1992, 174(22):7428-7435.
[19] LORENZO V.Isolation and characterization of microcin E492 from
Klebsiella pneumoniae[J].Archives of Microbiology, 1984, 139(1):72-75.
[20] HÅVARSTEIN L S, HOLO H, NES I F.The leader peptide of colicin V shares consensus sequences with leader peptides that are common among peptide bacteriocins produced by gram-positive bacteria[J].Microbiology, 1994, 142(9):2383-2389.
[21] LAVIÑA M, GAGGERO C, MORENO F.Microcin H47, a chromosome-encoded microcin antibiotic of
Escherichia coli[J].Journal of Bacteriology, 1990, 172(11):6585-6588.
[22] BONELLI R R, WIEDEMANN I, SAHL H G.Lantibiotics, including nisin[M]//KASTIN A J.Handbook of biologically active peptides.San Diego, CA:Academic Press, 2006:1139-1145.
[23] SKAUGEN M, NISSEN-MEYER J, JUNG G, et al.
In vivo conversion of
L-serine to
D-alanine in a ribosomally synthesized polypeptide[J].Journal of Biological Chemistry, 1994, 269(44):27183-27185.
[24] COTTER P D, HILL C, ROSS R P.Bacterial lantibiotics:strategies to improve therapeutic potential[J].Current Protein & Peptide Science, 2005, 6(1):61-75.
[25] BIERBAUM G, SAHL H G.Lantibiotics:mode of action, biosynthesis and bioengineering[J].Current Pharmaceutical Biotechnology, 2009, 10(1):2-18.
[26] KEMPERMAN R, KUIPERS A, KARSENS H, et al.Identification and characterization of two novel clostridial bacteriocins, circularin A and closticin 574[J].Applied and Environmental Microbiology, 2003, 69(3):1589-1597.
[27] NES I F, YOON S, DIEP D B.Ribosomally synthesiszed antimicrobial peptides (bacteriocins) in lactic acid bacteria:a review[C]//Food Science and Biotechnology.Netherlands:Springer, 2007, 16:675-690.
[28] OMAN T J, BOETTCHER J M, WANG H, et al.Sublancin is not a lantibiotic but an S-linked glycopeptide[J].Nature Chemical Biology, 2011, 7(2):78-80.
[29] STEPPER J, SHASTRI S, LOO T S, et al.Cysteine S-glycosylation, a new post-translational modification found in
Glycopeptide bacteriocins[J].FEBS Letters, 2011, 585(4):645-650.
[30] REA M C, ROSS R P, COTTER P D, et al.Classification of bacteriocins from Gram-positive bacteria[M]//DRIDER D, REBUFFAT S.Prokaryotic antimicrobial peptides:from genes to applications.New York:Springer, 2011:29-53.
[31] WIEDEMANN I, BREUKINK E, VAN KRAAIJ C, et al.Specific binding of nisin to the peptidoglycan precursor lipid Ⅱ combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity[J].Journal of Biological Chemistry, 2001, 276(3):1772-1779.
[32] EIJSINK V G H, AXELSSON L, DIEP D B, et al.Production of class Ⅱ bacteriocins by lactic acid bacteria:an example of biological warfare and communication[J].Antonie Van Leeuwenhoek, 2002, 81(1/2/3/4):639-654.
[33] KORDEL M, SCHVLLER F, SAHL H.Interaction of the pore forming-peptide antibiotics Pep 5, nisin and subtilin with non-energized liposomes[J].FEBS Letters, 1989, 244(1):99-102.
[34] ABEE T, KROCKEL L, HILL C.Bacteriocins:modes of action and potentials in food preservation and control of food poisoning[J].International Journal of Food Microbiology, 1995, 28(2):169-185.
[35] SONG H J, RICHARD J.Antilisterial activity of three bacteriocins used at sub minimal inhibitory concentrations and cross-resistance of the survivors[J].International Journal of Food Microbiology, 1997, 36(2/3):155-161.
[36] DAVIDSON B E. Bacteriocin piscicolin 126:us, 6054163[P].2000-04-25.
[37] 王全溪, 林滉, 贾洪强, 等.乳酸菌素对肉鸡血清生化指标和抗氧化功能的影响[J].动物营养学报, 2012, 24(1):131-136.
[38] GARNEAU S, VEDERAS J C.Update on the development of a novel dry cow therapy using a bismuth-based intramammary teat seal in combination with the bacteriocin lacticin 3147[J].Biochimie, 2002, 84(5):577-592.
[39] COCONNIER M H, LIEVIN V, HEMERY E, et al.Antagonistic activity against
Helicobacter infection
in vitro and
in vivo by the human
Lactobacillus acidophilus strain LB[J].Applied and Environmental Microbiology, 1998, 64(11):4573-4580.
[40] CRUCHET S, OBREGON M C, SALAZAR G, et al.Effect of the ingestion of a dietary product containing
Lactobacillus johnsonⅡ La1 on
Helicobacter pylori colonization in children[J].Nutrition, 2003, 19(9):716-721.
[41] LESBROS-PANTOFLICKOVA D, CORTHSY-THEULAZ I, BLUM A L.
Helicobacter pylori and probiotics[J].The Journal of Nutrition, 2007, 137(3 Suppl.2):812S-818S.
[42] DE VUYST L, LEROY F.Bacteriocins from lactic acid bacteria:production, purification, and food applications[J].Journal of Molecular Microbiology and Biotechnology, 2007, 13(4):194-199.
[43] GILLOR O, ETZION A, RILEY M A.The dual role of bacteriocins as anti-and probiotics[J].Applied Microbiology and Biotechnology, 2008, 81(4):591-606.
[44] REA M C, SIT C S, CLAYTON E, et al.Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against
Clostridium difficile[J].Proceedings of the National Academy of Sciences of the United States of America, 2010, 107(20):9352-9357.
[45] CORR S C, LI Y, RIEDEL C U, et al.Bacteriocin production as a mechanism for the antⅡnfective activity of
Lactobacillus salivarius UCC118[J].Proceedings of the National Academy of Sciences of the United States of America, 2007, 104(18):7617-7621.
[46] CASEY P G, GARDINER G E, CASEY G, et al.A five-strain probiotic combination reduces pathogen shedding and alleviates disease signs in pigs challenged with
Salmonella enterica Serovar Typhimurium[J].Applied and Environmental Microbiology, 2007, 73(6):1858-1863.
[47] WALSH M C, GARDINER G E, HART O M, et al.Predominance of a bacteriocin-producing
Lactobacillus salivarius component of a five-strain probiotic in the porcine ileum and effects on host immune phenotype[J].FEMS Microbiology Ecology, 2008, 64(2):317-327.
[48] MADSEN K, CORNISH A, SOPER P, et al.Probiotic bacteria enhance murine and human intestinal epithelial barrier function[J].Gastroenterology, 2001, 121(3):580-591.
[49] CORR S C, GAHAN C G, HILL C.Impact of selected
Lactobacillus and
Bifidobacterium species on
Listeria monocytogenes infection and the mucosal immune response[J].FEMS Immunology and Medical Microbiology, 2007, 50(3):380-388.
[50] VAN HEMERT S, MEIJERINK M, MOLENAAR D, et al.Identification of
Lactobacillus plantarum genes modulating the cytokine response of human peripheral blood mononuclear cells[J].BMC Microbiology, 2010, 10(1):293.
[51] WALSH M C, GARDINER G E, HART O M, et al.Predominance of a bacteriocin-producing
Lactobacillus salivarius component of a five-strain probiotic in the porcine ileum and effects on host immune phenotype[J].FEMS Microbiology Ecology, 2008, 64(2):317-327.
[52] MEIJERINK M, VAN HEMERT S, TAVERNE N, et al.Identification of genetic loci in
Lactobacillus plantarum that modulate the immune response of dendritic cells using comparative genome hybridization[J].PLoS ONE, 2010, 5(5):e10632.
[53] ROSSI L M, RANGASAMY P, ZHANG J, et al.Research advances in the development of peptide antibiotics[J].Journal of Pharmaceutical Sciences, 2008, 97(3):1060-1070.
[54] SMITH L, HILLMAN J.Therapeutic potential of type A (I) lantibiotics, a group of cationic peptide antibiotics[J].Current Opinion in Microbiology, 2008, 11(5):401-408.
[55] QIU X Q, ZHANG J, WANG H, et al.A novel engineered peptide, a narrow-spectrum antibiotic, is effective against vancomycin-resistant Enterococcus faecalis[J].Antimicrobial Agents and Chemotherapy, 2005, 49(3):1184-1189.
[56] REA M C, DOBSON A, O'SULLIVAN O, et al.Effect of broad-and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon[J].Proceedings of the National Academy of Sciences of the United States of America, 2010, 108(Suppl.1):4639-4644.
[57] 邓凯, 张日俊.细菌素subticin112对小鼠的急性毒性作用研究[J].动物营养学报, 2011, 23(8):1446-1452.
[58] SHIN M S, HAN S K, JI A R, et al. Isolation and characterization of bacteriocin-producing bacteria from the gastrointestinal tract of broiler chickens for probiotic use[J].Journal of Applied Microbiology, 2008, 105:1364-5072.
[59] LOPEZ F E, VINCENT P A, ZENOFF A M, et al.Efficacy of microcin J25 in biomatrices and in a mouse model of
Salmonella infection[J].Journal of Antimicrobial Chemotherapy, 2007, 59(4):676-680.
京公网安备 11010802041926号